US EditionJ&J Absorbs Stelara, Tariff Hits to Deliver Beat-and-Raise Quarter
9 Articles
9 Articles
China is the US president's primary target, believes the Deputy CEO of the Finnish Chamber of Commerce. Finnish pharmaceutical companies are closely monitoring the situation.
J&J Beats Sales Expectations While Trump Threatens Tariffs
Johnson & Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as the pharmaceutical industry faces the dual threats of tariffs and a crackdown on drug pricing.
Zero Hedge
thelibertybeacon.comCharting The U.S. Pharma Supply Chain As Trump Threatens 200% Tariffs
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
July 16, 2025, foreign news agencies reported that US President Donald Trump is preparing a plan to collect import taxes on drugs by announcing that the US will proceed with collecting taxes by the end of July. The US will start collecting taxes at a low rate first to give pharmaceutical companies time to relocate their production bases to the US before collecting taxes at a higher rate in about a year from now. President Donald Trump said there…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
